CBD Oil for Drug and Nicotine Addiction and Withdrawal


Cbd Oil  can reduce some aspects of drug and nicotine withdrawal in dependent cigarette smokers and opioid dependent addicts.

Unfortunately, the last several years have seen a HUGE uptick in both opioid addiction and overdose. The death rate for opioids has increased so significantly in such a short time, that it is considered by many to be at crisis levels.

The National Institute on Drug Abuse, a division of the National Institutes of Health, has updated their website to reflect recent NIDA research on the effects of medical cannabis legalization on prescription opioid use outcomes.

The preliminary figures from the National Center for Health Statistics suggest that there were more than 64,000 drug overdose deaths in 2016. And in a shocking — but not quite surprising — reveal, synthetic opioids like fentanyl overtook both heroin and prescription painkillers in terms of overdose deaths.

The American Society of Disease Medicine characterizes addiction by a subject’s “inability to consistently abstain, impairment in behavioral control, craving, diminished recognition of significant problems with one’s behaviors and interpersonal relationships, and a dysfunctional emotional response. Like other chronic diseases, addiction often involves cycles of relapse and remission. Without treatment or engagement in recovery activities, addiction is progressive and can result in disability or premature death.”

Nicotine cravings alleviated by CBD

Similar findings were observed in a study carried out by University College London, in which cigarette smokers were given an inhaler containing CBD. 24 smokers were recruited and split into two groups: the CBD and the placebo. Both groups were encouraged to use their inhaler whenever they felt the urge to smoke a cigarette. The group using the CBD inhaler found that they smoked 40% less cigarettes, compared to the placebo group where there was no change.

According to the CDC, “The United States is in the midst of an opioid overdose epidemic. The epidemic is increasing at an alarming rate every year. And nearly half of all opioid overdose deaths involve a prescription opioid.” As they state, these deaths have increased partly because of a large increased in prescribed painkillers, and also because of the increase in cheap street heroin supplies.

Cannabidiol (CBD), is a cannabinoid in the hemp plant that may show promise in opioid remediation. THC has been well documented to enhance sensitivity to other drugs, a staple of the “gateway drug” theory. However, cannabidiol acts in the opposite way.7 From clinical studies involving rats, it appears to have a very low abuse potential and to inhibit drug-seeking behavior. Researchers have found that CBD has a longer drawn out effect up to two weeks after administration.

Methadone must be administered daily to stop drug seeking behavior in the patient. This study was an animal study, and it may have issues translating to a human context. But it does suggest that there is much hope in using CBD oil to help with withdrawal from opiates.

Reducing Cigarette Cravings with CBD Oil

In 2013 a study found that in two groups of people who wished to quit smoking, those treated with CBD oil reduced the number of cigarettes smoked by approximately 40%.(National Institute of Health)

There’s been some buzz about CBD oil being helpful to people trying to quit cigarettes, and one small, short-term study published in 2013 in the journal Addictive Behaviors supports this idea. A group of 24 smokers received inhalers with either CBD or a placebo substance and were encouraged to use those inhalers for a week whenever they felt the urge to smoke.

Those with the placebo inhaler did not reduce their cigarette consumption at all during that week, but those with the CBD inhaler reduced theirs by about 40%.

The results “suggest CBD to be a potential treatment for nicotine addiction,” the study authors wrote—but they also admit that their findings are preliminary. Ryan Vandrey, PhD, a cannabis researcher and associate professor of psychiatry at Johns Hopkins University (who was not involved in the 2013 study), agrees that larger, longer-term studies are needed to know if CBD might be helpful for smokers looking to kick the habit.

Studies suggest there may be a link between the endocannabinoid system and nicotine addiction, and CBD may be the key to breaking the habit. CBD hemp oil may help curb the urge to smoke by reducing “reward memories” which cause people to want to smoke when they see another person smoking.

According to a 2015 report put out by the National Institute on Drug Abuse, a division of the National Institutes of Health, nicotine is often as addictive as heroin and cocaine. Nicotine stimulates the release of dopamine, a powerful neurotransmitter, in the pleasure circuits of the brain. Once a person is addicted to nicotine, their brain continually craves the nicotine so more dopamine will be released and give them those intense pleasurable sensations again.

The report goes on to say that about thirty-five million people know that smoking is bad for their health and want to break their nicotine habit. However, more than eighty-five percent of those who try to stop using tobacco products end up having a relapse, often within the first week when the withdrawal symptoms are the most severe.

Can CBD help break the nicotine habit?

A small research project designed to investigate this very question strongly suggests that CBD (cannabidiol) can indeed help break a nicotine habit. This is huge news because breaking a nicotine addiction is obviously no major feat! CBD, scientifically known as cannabidiol, is the primary non-psychoactive cannibinoid found in therapeutic cannabis plants. This should not be confused with THC (tetrahydrocannabidiol) found in recreational marijuana that gets people high. CBD will not get you high at all, nor will it give you a buzz like nicotine.

The research study was led by Dr. CJ Morgan, a member of the Clinical Psychopharmacology Unit at the University College of London. It was published in 2013 in the journal, Addictive Behaviors.

Twenty-four smokers were chosen at random and split into two equal groups. All smokers were given an inhaler and also given instructions on how to use it. They were told to use the inhaler any time they felt the urge to smoke for a period of one week. Note, they were not actually told to stop smoking or to reduce their smoking habits, only to use the inhaler any time they felt the urge to smoke. This is a key point so keep it in mind.

Half of the inhalers contained CBD and the other half contained no CBD, only a placebo. None of the participants knew if their inhaler contained CBD or not. Even though this was a small study, with only twelve participants in each group, the results were very convincing.

The group that received the placebo in their inhaler showed no significant difference in how many cigarettes they smoked that week. HOWEVER, the group that received CBD in their inhaler reduced their cigarette consumption by about forty percent. This remarkable result was achieved without even telling them to stop or reduce their smoking! It’s also good to note that the effect seemed to linger past the one week experiment, indicating that the positive effect of the CBD continues even after people stop taking it, at least for a while.

This is very encouraging and backs up the anecdotal accounts of how vaping CBD and using CBD oil under the tongue, reduces the withdrawal symptoms and intense cravings when one is attempting to break the nicotine habit.

CBD repairs damage caused to the brain by addiction

Serious addiction ravages the body, but also causes long term neurodegeneration, associated with the over-activation of glutamate receptors resulting in a progressive loss of neurons.

CBD has been patented by the US Federal government as a neuroprotectant due to its powerful antioxidant and anti-inflammatory properties. Its ability to inhibit glutamate transmission also makes it of particular interest in combatting the damage caused by alcohol or drug related neurotoxicity.



    1. Bachhuber, M.A., Saloner, B., Cunningham, C.O., and Barry, C.L. (2014). Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States, 1999–2010. JAMA Internal Medicine174(10), 1668–1673. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4392651/.
    1. Bisaga, A., Sullivan, M.A., Glass, A., Mishlen, K., Pavlicova, M., Haney, M., Raby, W.N., Levin, F.R., Carpenter, K.M., Mariani, J.J., and Nunes, E.V. (2015, September 1). The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone. Drug and Alcohol Dependence, 154, 38-45. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536087/.
    1. DrugFacts: Heroin. (2014, October). National Institute on Drug Abuse. Retrieved from http://www.drugabuse.gov/publications/drugfacts/heroin.
    1. Heroin Addiction. (n.d.). Addictions.com. Retrieved from http://www.addictions.com/heroin/.
    1. Lucas, P., Reiman, A., Earleywine, M., McGowan, S.K., Oleson, M., Coward, M.P. and Thomas, B. (2012). Cannabis as a substitute for alcohol and other drugs: A dispensary-based survey of substitution effect in Canadian medical cannabis patients. Addiction Research and Theory, Early Online, 1-8. Retrieved from http://www.tandfonline.com/doi/full/10.3109/16066359.2012.733465?needAccess=true.
    1. Maldonado, R., Valverde, O., and Berrendero, F. (2006, April). Involvement of the endocannabinoid system in drug addiction. Trends in Neurosciences, 29(4), 225-32. Retrieved from http://www.cell.com/trends/neurosciences/abstract/S0166-2236(06)00025-7?_returnURL=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0166223606000257%3Fshowall%3Dtrue.
    1. Morel, L.J., Giros, B., and Dauge, V. (2009, October). Adolescent exposure to chronic delta-9-tetrahydrocannabinol blocks opiate dependence in maternally deprived rats. Neuropsychopharmacology, 34(11), 2469-76. Retrieved from http://www.nature.com/npp/journal/v34/n11/full/npp200970a.html.
    1. Reiman, A. (2009). Cannabis as a substitute for alcohol and other drugs. Harm Reduction Journal6, 35. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2795734/.
    1. Valverde, O., Noble, F., Beslot, F., Dauge, V., Fournie-Zaluski, M.C., and Roques, B.P. (2001, May). Delta9-tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effect. European Journal of Neuroscience, (13)9, 1816-24. Retrieved from http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.0953-816x.2001.01558.x/full.
  1. Walsh, Z., Gonzalez, R., Crosby, K., S Thiessmen, M., Carroll, C., and Bonn-Miller, M.O. (2016, October 12). Medical cannabis and mental health: A guided systematic review. Clinical Psychology Review, 51, 15-29. Retrieved from http://www.sciencedirect.com/science/article/pii/S0272735816300939.
Disclaimer : This website contains general information about cbd oil and the possible health benefits. The information is not advice and is not a substitute for advice from a healthcare professional. You must not rely on the information  as an alternative to medical advice from your doctor or other professional healthcare providers. FDA Disclosure:CBD products are not approved by the FDA for the diagnosis, cure, mitigation, treatment, or prevention of any disease. While we publish and refer to currently available research on cannabidiol, terpenoids and other properties of hemp-derived cannabis oils, it is important to note: None of the products or information available on this website are intended to be a treatment protocol for any disease state. The information presented is for educational purposes only and should not be construed as medical advice or instruction.  The FDA would want us to remind you: You should always seek the advice of a physician before adding any supplements to your diet.

Leave a Reply

Your email address will not be published. Required fields are marked *